Hiroshi Ishihara
Asia-Pacific Guide 2024
Band 3 : Life Sciences
Email address
[email protected]Contact number
81-3-6775-1067Share profile
Band 3
About
Provided by Hiroshi Ishihara
Practice Areas
Hiroshi Ishihara specializes in the healthcare and life sciences industry. He handles many commercial transactions, such as M&A of pharmaceutical companies and license agreements, and has extensive experience in international and domestic M&A transactions. He also advises clients on regulations relating to drugs, medical devices, and regenerative medicine.
Career
Admitted in Japan (2000); Admitted in California (2006); Admitted in New York (2007); Visiting Attorney at Kirkland & Ellis LLP (2005 - 2006); Seconded to the Bank of Japan and a general trading company in Japan
Professional Memberships
Dai-ichi Tokyo Bar Association (Japan), 2000; State Bar of California (USA), 2006; New York State Bar Association (USA), 2007; Advisor to the Medical Affairs Study Group of the Japan Pharmaceutical Industry Legal Affairs Association (Japan)
Publications
“Digital Healthcare 2023 – Japan” (Chambers Global Practice Guide, 2023); “Amendment to Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices” (LexisNexis 2022); “Legal Matters regarding Life Sciences and Health Care - Navigation regarding Regulations, Intellectual Properties and Corporate Matters (Second Edition)” (Shoji-homu 2020)
Personal
University of Tokyo (Bachelor of Economics, 1997); Keio University (LLB, 2004); Columbia University School of Law (LLM, 2005)
Chambers Review
Asia-Pacific
Hiroshi Ishihara is co-head of Anderson Mori's healthcare, pharmaceutical and life sciences department, and he routinely advises clients on regulatory issues and handles commercial transactions, such as licence agreements.
Strengths
Provided by Chambers
"He is honest and humble, and we trust him very much."
"He is honest and humble, and we trust him very much."
Discover other Lawyers at
Anderson Mori & Tomotsune
Asia-Pacific Region
Japan
